Craig McDonald

13PUBLICATIONS
68CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersNeurology and neuromuscular diseasesMedical virologyOrthopaedics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 01, 2026
Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up.

|Jun 04, 2026
Five-Year Outcomes With Delandistrogene Moxeparvovec in Patients With Duchenne Muscular Dystrophy: A Phase 1/2a Study.

|May 26, 2026
A Validated Prognostic Score for Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy.

|Jun 27, 2025
Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophy.

Francesco Muntoni, James Signorovitch, Nathalie Goemans

|Oct 09, 2024
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.

Jerry R Mendell, Francesco Muntoni, Craig M McDonald

|May 06, 2024
Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial.

Marianela Schiava, Michael P McDermott, Jonathan Broomfield

Pageof 3

Frequent Collaborators

3 joint publications

Heather Gordish-Dressman

3 joint publications

Francesco Muntoni

2 joint publications

Volker Straub

2 joint publications

Eric P Hoffman